Jennifer Kay

9PUBLICATIONS

26CO-AUTHORS

Molecular targetsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)Cancer cell biologyEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 25, 2026

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

|Nov 19, 2025

Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

Lee J Pribyl, Jennifer E Kay, Joshua J Corrigan

|Jun 04, 2025

Sex and Alkyladenine DNA Glycosylase Expression are Key Susceptibility Factors for NDMA-induced Mutations, Toxicity, and Cancer.

Jennifer E Kay, Joshua J Corrigan, Lindsay B Volk

|Jan 10, 2024

Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data.

Jennifer E Kay, Julia Green Brody, Megan Schwarzman

|Oct 14, 2022

Novel In Vivo CometChip Reveals NDMA-Induced DNA Damage and Repair in Multiple Mouse Tissues.

Norah A Owiti, Joshua J Corrigan, Lee J Pribyl

|Aug 19, 2022

Chemical Effects on Breast Development, Function, and Cancer Risk: Existing Knowledge and New Opportunities.

Jennifer E Kay, Bethsaida Cardona, Ruthann A Rudel

Pageof 2

Frequent Collaborators

Bevin P Engelward

John M Essigmann

Lee J Pribyl

Lindsay B Volk

Forest M White

Joshua J Corrigan

Norah A Owiti

Ilana S Nazari

Ruthann A Rudel

Sofie Christiansen

Frequent Collaborators

Bevin P Engelward

John M Essigmann

Lee J Pribyl

Lindsay B Volk